Health and Human Services Office of the Assistant Secretary for Preparedness (HHS ASPR) implemented a federal program called Special Projects for Equitable and Efficient Distribution (SPEED) for the allocation of the COVID-19 monoclonal antibodies (mAb). SPEED is aimed at assisting states in the identification of non-hospital/non-hospital-affiliated facilities who care for and serve priority populations, including nursing homes and assisted living facilities, for allocating mAb for administration to their patient population. SPEED is separate from the state-based mAb allocation system but is complementary.
The SPEED Program includes:
- Home infusion in nursing homes and assisted living facilities
- Home infusion providers in 46 states and DC will dispense and provide nursing support for administration of mAbs to residents of nursing homes and assisted living facilities
- Partner: National Home Infusion Association
- Direct allocation to long-term care pharmacies
- Long-term care pharmacies will be pre-positioned with mAbs to deploy when cases occur in nursing homes and assisted living communities served by each pharmacy
- Partners: American Society of Consultant Pharmacists and AMDA-The Society for Post-Acute and Long-Term Care Medicine